Amarin Says REDUCE-IT Post Hoc Analysis Showed About 30% Relative Risk Reduction In Major Adverse Cardiovascular Events Among Patients On Icosapent Ethyl At Least 1.5 Years; Hazard Ratio Of 0.73 Persisted After Discontinuation

Loading news article.

Amarin Says REDUCE-IT Post Hoc Analysis Showed About 30% Relative Risk Reduction In Major Adverse Cardiovascular Events Among Patients On Icosapent Ethyl At Least 1.5 Years; Hazard Ratio Of 0.73 Persisted After Discontinuation | WAPE

Amarin Says REDUCE-IT Post Hoc Analysis Showed About 30% Relative Risk Reduction In Major Adverse Cardiovascular Events Among Patients On Icosapent Ethyl At Least 1.5 Years; Hazard Ratio Of 0.73 Persisted After Discontinuation

Article summary

Related companies

Analyzed by WAPE AI.

Comments —